Rapid DFLC Response Predict CHR in AL Amyloidosis
- Conditions
- Systemic AL Amyloidosis
- Interventions
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06627309
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
🇨🇳Fuxing Hospital affiliated to Capital Medical University, Beijing, Beijing, China
Treatment Duration of IPA
- Conditions
- Invasive AspergillosisAntifungal Therapy
- First Posted Date
- 2024-09-04
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06583512
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia
- Conditions
- Relapsed Adult ALLB-cell Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic LeukemiaRelapsed Pediatric ALL
- Interventions
- Biological: Senl_B19 autologous CAR-T (S1904) treatment
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT06581081
- Locations
- 🇨🇳
Peking University People'S Hospital, Beijing, Beijing, China
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06577909
- Locations
- 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry
- Conditions
- Myelodysplastic Syndromes
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 163
- Registration Number
- NCT06569095
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, China
🇨🇳Wuhan TongJi Hospital, Wuhan, China
The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
- Conditions
- CLL
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06557304
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
- Conditions
- Mismatch Repair DeficiencyEndometrioid CarcinomaEndometrial Cancer
- Interventions
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06549855
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency
- Conditions
- Pregnancy RelatedProtein S Deficiency
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT06531525
- Locations
- 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing/Beijing, China
Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia Assessed by Deep Learning
- Conditions
- Cirrhosis, LiverSarcopenia
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06531200
NAC for Hematopoietic Recovery in SAA
- Conditions
- Aplastic Anemia
- Interventions
- Drug: N Acetyl L Cysteine
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06518044